Neuralace Medical recently received FDA clearance of Axon Therapy for diabetic patients suffering from chronic painful neuropathy. The EpidStrategies medical device trials team of consultants was led by Xiaohui Jiang, Josie Gauthier, Gina Nicholson, and Heidi Reichert. Please contact Heidi Reichert if you would like to learn more about EpidStrategies’ statistical services or our medical device trials team.
To read more, click here: Neuralace Medical Announces FDA Clearance of Axon Therapy for Chronic Painful Diabetic Neuropathy – Neuralace